Drug Discovery World

DECEMBER 6, 2023

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%

Government 147

Government Pharma Companies Science International 147

Drug Discovery World

JANUARY 24, 2024

Once the big pharma companies join the race for a specific disease or target, the window of opportunity to be successful as an independent biotech company is already closed.

Small Molecule 147

Small Molecule Research Pharma Companies Disease 147

Drug Discovery World

FEBRUARY 2, 2024

He says: “Then, maybe in 2025/2026, we’re ready to apply vast and dramatic AI models, because then we’ll have it.” If I hadn’t had that,” he says, “I would certainly not be working at Tetra, today.”

Compliance 130

Compliance Science Pharma Companies Engineering 130

Drug Discovery World

OCTOBER 4, 2022

The global lab automation market for drug discovery is expected to grow by a CAGR of 5% between 2021 – 2026, according to a report by Mordor Intelligence. . This year has seen some major deals announced by big pharma companies. Collaborations have and will always be an important part of this industry.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130